Renata Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RENATA, and what generic and branded alternatives to RENATA drugs are available?
RENATA has five approved drugs.
Summary for Renata
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Renata
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renata | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 207062-001 | Oct 31, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Renata | RISPERIDONE | risperidone | TABLET;ORAL | 078707-006 | Dec 29, 2008 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Renata | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 207062-003 | Oct 31, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Renata | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 207062-004 | Oct 31, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Renata | FROVATRIPTAN SUCCINATE | frovatriptan succinate | TABLET;ORAL | 213891-001 | Apr 6, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Renata | RISPERIDONE | risperidone | TABLET;ORAL | 078707-005 | Dec 29, 2008 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Renata | RISPERIDONE | risperidone | TABLET;ORAL | 078707-001 | Dec 29, 2008 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
